# Genepoc, Inc.

- Location (FDA's records): Quebec, CA
- FDA decisions: 5 (2017–2019): 5 510(k) clearances
- Product codes: NJR (1), OZN (1), PGX (1), OOI (1), PMY (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 3 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Becton, Dickinson & CO: 1 (https://510kreport.com/company/becton-dickinson)
- Geneohm Sciences Canada, Inc. (Bd Diagnostics): 1 (https://510kreport.com/company/geneohm-sciences-canada-bd-diagnostics)
- Cepheid: 1 (https://510kreport.com/company/cepheid)

## Firms that cite its devices most
- Meridian Bioscience, Inc.: 1 (https://510kreport.com/company/meridian-bioscience)
- Vela Operations USA: 1 (https://510kreport.com/company/vela-operations-usa)
- Diasorin Molecular, LLC: 1 (https://510kreport.com/company/diasorin-molecular)

## Its most-cited devices
- K170557: GenePOC GBS LB (2017), cited by 1
- K172569: GenePOC CDiff (2017), cited by 1
- K170558: revogene (2017), cited by 1

## Recent decisions
- K190275: GenePOC Carba (May 10, 2019)
- K183366: GenePOC Strep A (Mar 6, 2019)
- K172569: GenePOC CDiff (Nov 22, 2017)
- K170557: GenePOC GBS LB (May 25, 2017)
- K170558: revogene (May 25, 2017)

Source page: https://510kreport.com/company/genepoc